Cargando…
COVID-19-Vaccine-Pfizer-BioNTech/mRNA-1273: Type 2 diabetes mellitus, hyperosmolar hyperglycaemic syndrome and diabetic ketoacidosis: 3 case reports
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642216/ http://dx.doi.org/10.1007/s40278-021-06468-3 |
Ejemplares similares
-
COVID-19-Vaccine-Pfizer-BioNTech/mRNA-1273: Various toxicities: 13 case reports
Publicado: (2021) -
COVID 19 Vaccine Pfizer BioNTech/mRNA-1273/ravulizumab: Various toxicities: 5 case reports
Publicado: (2021) -
Pfizer-BioNTech (BNT162b2), Moderna (mRNA-1273) COVID-19 mRNA vaccines and hypersensitivity reactions
por: Haq, Hannah N., et al.
Publicado: (2022) -
Comparative effectiveness over time of the mRNA-1273 (Moderna) vaccine and the BNT162b2 (Pfizer-BioNTech) vaccine
por: Islam, Nazmul, et al.
Publicado: (2022) -
Covid-19-vaccine-Pfizer-BioNTech/mRNA-1273: IgA nephropathy and reactivation of glomerulonephritis: 4 case reports
Publicado: (2021)